Buy stocks on the dip? Here’s a better strategy.

Many investors welcomed the market’s recent decline as an opportunity to buy the dip. That’s not the best strategy, argue two ...

Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific ...